Cargando…
Myocarditis Following COVID-19 Vaccination
Myocarditis is an established but rare adverse event following administration of messenger RNA–based coronavirus disease 2019 (COVID-19) vaccines and is most common in male adolescents and young adults. Symptoms typically develop within a few days of vaccine administration. Most patients have mild a...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973554/ https://www.ncbi.nlm.nih.gov/pubmed/36863817 http://dx.doi.org/10.1016/j.hfc.2022.08.012 |
_version_ | 1784898550851698688 |
---|---|
author | Marschner, Constantin A. Shaw, Kirsten E. Tijmes, Felipe Sanchez Fronza, Matteo Khullar, Sharmila Seidman, Michael A. Thavendiranathan, Paaladinesh Udell, Jacob A. Wald, Rachel M. Hanneman, Kate |
author_facet | Marschner, Constantin A. Shaw, Kirsten E. Tijmes, Felipe Sanchez Fronza, Matteo Khullar, Sharmila Seidman, Michael A. Thavendiranathan, Paaladinesh Udell, Jacob A. Wald, Rachel M. Hanneman, Kate |
author_sort | Marschner, Constantin A. |
collection | PubMed |
description | Myocarditis is an established but rare adverse event following administration of messenger RNA–based coronavirus disease 2019 (COVID-19) vaccines and is most common in male adolescents and young adults. Symptoms typically develop within a few days of vaccine administration. Most patients have mild abnormalities on cardiac imaging with rapid clinical improvement with standard treatment. However, longer term follow-up is needed to determine whether imaging abnormalities persist, to evaluate for adverse outcomes, and to understand the risk associated with subsequent vaccination. The purpose of the review is to evaluate the current literature related to myocarditis following COVID-19 vaccination, including the incidence, risk factors, clinical course, imaging findings, and proposed pathophysiologic mechanisms. |
format | Online Article Text |
id | pubmed-9973554 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99735542023-03-01 Myocarditis Following COVID-19 Vaccination Marschner, Constantin A. Shaw, Kirsten E. Tijmes, Felipe Sanchez Fronza, Matteo Khullar, Sharmila Seidman, Michael A. Thavendiranathan, Paaladinesh Udell, Jacob A. Wald, Rachel M. Hanneman, Kate Heart Fail Clin Article Myocarditis is an established but rare adverse event following administration of messenger RNA–based coronavirus disease 2019 (COVID-19) vaccines and is most common in male adolescents and young adults. Symptoms typically develop within a few days of vaccine administration. Most patients have mild abnormalities on cardiac imaging with rapid clinical improvement with standard treatment. However, longer term follow-up is needed to determine whether imaging abnormalities persist, to evaluate for adverse outcomes, and to understand the risk associated with subsequent vaccination. The purpose of the review is to evaluate the current literature related to myocarditis following COVID-19 vaccination, including the incidence, risk factors, clinical course, imaging findings, and proposed pathophysiologic mechanisms. Elsevier Inc. 2023-04 2023-02-28 /pmc/articles/PMC9973554/ /pubmed/36863817 http://dx.doi.org/10.1016/j.hfc.2022.08.012 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Marschner, Constantin A. Shaw, Kirsten E. Tijmes, Felipe Sanchez Fronza, Matteo Khullar, Sharmila Seidman, Michael A. Thavendiranathan, Paaladinesh Udell, Jacob A. Wald, Rachel M. Hanneman, Kate Myocarditis Following COVID-19 Vaccination |
title | Myocarditis Following COVID-19 Vaccination |
title_full | Myocarditis Following COVID-19 Vaccination |
title_fullStr | Myocarditis Following COVID-19 Vaccination |
title_full_unstemmed | Myocarditis Following COVID-19 Vaccination |
title_short | Myocarditis Following COVID-19 Vaccination |
title_sort | myocarditis following covid-19 vaccination |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973554/ https://www.ncbi.nlm.nih.gov/pubmed/36863817 http://dx.doi.org/10.1016/j.hfc.2022.08.012 |
work_keys_str_mv | AT marschnerconstantina myocarditisfollowingcovid19vaccination AT shawkirstene myocarditisfollowingcovid19vaccination AT tijmesfelipesanchez myocarditisfollowingcovid19vaccination AT fronzamatteo myocarditisfollowingcovid19vaccination AT khullarsharmila myocarditisfollowingcovid19vaccination AT seidmanmichaela myocarditisfollowingcovid19vaccination AT thavendiranathanpaaladinesh myocarditisfollowingcovid19vaccination AT udelljacoba myocarditisfollowingcovid19vaccination AT waldrachelm myocarditisfollowingcovid19vaccination AT hannemankate myocarditisfollowingcovid19vaccination |